US Warrant News

PlasmaTech Biopharmaceuticals closes underwritten public offering of common …News-Medical.netPlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI, PTBIW), a biopharmaceutical company advancing patient care in critical areas, announced the closing of an underwritten public offering of 3,500,000 shares of common stock, and warrants to purchase …PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public OfferingCNNMoney all 3 news articles …read more

PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public OfferingCNNMoneyThe Company has also granted the underwriters a 45-day option to purchase up to an additional 525,000 shares of common stock and/or 525,000 warrants to cover over-allotments, if any. H.C. Wainwright & Co. and Aegis Capital Corp. are acting as joint … and more …read more

PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public OfferingMarketWatchThe Company has also granted the underwriters a 45-day option to purchase up to an additional 525,000 shares of common stock and/or 525,000 warrants to cover over-allotments, if any. H.C. Wainwright & Co. and Aegis Capital Corp. are acting as joint … and more …read more

Interleukin Genetics snags $10 mlnThomson Reuters’ peHUB (press release)Pursuant to the purchase agreement, the Company has agreed to issue an aggregate of 50,099,700 shares of the Company’s common stock at a price per share of $0.1003, as well as warrants to purchase up to an aggregate of 50,099,700 shares of common … …read more

Palatin Completes $20 Million Equity and $10 Million Debt FinancingsCNNMoneyThe Series C warrants are subject to limitation on exercise if QVT and its affiliates would beneficially own more than 9.99% (4.99% for the other accredited investment fund holder) of the total number of Palatin’s shares of common stock following such … and more …read more

Harte Gold Announces Initial Closing Under Private PlacementMarketWatchFinder’s fees payable under the private placement consist of a cash payment equal to 5% of cash raised and that number of common share purchase warrants equal to 5% of the number of Units and FT Units issued pursuant to certain orders, for a total of … and

ParkerVision Receives $7 Million Litigation Funding CommitmentGlobeNewswire (press release)Funder has also entered into a Warrant Subscription Agreement (“Warrant Agreement”) for the right to purchase up to 5,652,174 shares of the Company’s common stock. The purchase price of the warrants is $1.3 million and will be paid to the Company in … and more …read more

Interleukin Genetics Raises $10 Million in FinancingsBusiness Wire (press release)In connection with the loan agreement, the Company has issued to Horizon warrants to purchase a total of 2,492,523 shares of common stock at a per share exercise price of $0.1003. The lender warrants have a term of 10 years. The Company has agreed to …

Vermillion (VRML) Announces $10.5M Private Placement; Ends ATM ProgramStreetInsider.com (subscription)In addition, the investors will receive warrants to purchase up to an aggregate of 4,166,659 shares of Vermillion common stock at an exercise price of $2.00 per share. The warrants become exercisable six months after the closing of the private … and more …read more

General Moly Announces $8.5 Million Private Placement FinancingJunior Mining NetworkEach unit consists of one senior convertible note due 2019 (the “Notes”) with principal value of $100 and 100 five-year warrants to purchase the Company’s common stock at $1.00 per share. The Notes, which are senior to any General Moly debt obligations … and more …read